Wilson Wolf Manufacturing invents, designs, and manufactures innovative cell culture devices and associated ancillary products. Our mission is to create hope for cancer patients, one device at a time. G-Rex® bioreactors, our flagship product line, are uniquely suited for the rapid expansion of immune cell types for academic research and commercial cell therapy manufacturing. We focus on the revolutionary field of T cell therapy, which is generating impressive clinical outcomes for once incurable cancer types. Wilson Wolf has partnered with Fresenius Kabi and Bio-Techne to form ScaleReady, a marketing, technical support, and commercialization organization focused on providing the most scalable cell therapy manufacturing platform in the industry. The spirit of the partnership and the ScaleReady business allows us to simplify T cell manufacturing by offering the most innovative solutions in the industry, both immediately and into the future, through collaborative development of new products that address the challenges of scaling a cell therapy. Contact us with questions or to learn how our expertise in the field of T cell therapy manufacturing can help your organization develop commercially viable, highly reliable and repeatable manufacturing processes.
External link for Wilson Wolf Manufacturing, LLC
2100 Old Highway 8 NW
St Paul, Minnesota 55112, US
33 5th Ave NW
St. Paul, Minnesota 55112, US
Wilson Wolf Manufacturing, LLC reposted this
Today the Wilson Foundation Minnesota announced a $2M donation to Caring Cross in support of its program of making CAR-T cell therapies affordable and accessible in underserved communities throughout the world. Read press release: https://bit.ly/3YkCgeq #CAR_TCellTherapy #HealthcareEquity #CancerTreatment #GlobalHealth
Wilson Wolf Manufacturing, LLC reposted this
Please add CellReady™ to the CGT list. CellReady™ is the only CGT CDMO that is solely dedicated to G-Rex-centric manufacturing. We also believe that CellReady™ is the only CGT CDMO that has an ownership structure that is absent venture funding or any other form of ownership structure that imposes a need to generate significant financial profit. Why is this important? It frees CellReady™ to provide CGT entities what they need most and have least. TIME and MONEY How is that possible? CellReady™ is playing the Infinite Game and has a mindset of abundance. It is willing and able to run close to breakeven with minimal profit. No quarterly financial targets, no need to drive towards a lucrative financial exit, no need to do anything that makes its clients become viewed as a source of money. Where does this lead? CellReady™ is likely the only CDMO with the sole goal of openly sharing its operational and technical approaches to manufacturing efficiency with the entire field of CGT, including competitive CDMOs. By doing that, CellReady™ intends to revolutionize the business model of CGT by democratizing the information that sets it apart from others. That will help set the field free of the existing time and money trap which has caused investment to dry up. With a mindset of abundance, one initiative that CellReady™ is helping to fund is a $20 million G-Rex Grant Program available at ScaleReady which provides every recipient with up to $300,000 of free products and services to accelerate their clinical enabling manufacturing work or to make manufacturing advancements for programs that are already in the clinical. Please check it out.
Enhanced Viral Vector Yield & Quality ~ Market Analyst @ Virica | Curated Cell & Gene Therapy Insights| Business Development | Biotechnology|
More than 400 CDMO’s in the small molecule, biologics, cell and gene therapy space! And that’s growing as demand for cell and gene therapy continues to rise! An overcrowded space means CDMOs must differentiate. Especially with several new entrants, including Lifeera, Kincell, and NewBiologix. Source: BioKnow #biomanufacturing #innovation #CDMOs
Wilson Wolf Manufacturing, LLC reposted this
We are happy to report that Applied Cells, specializing in cell separation, informed us that they will be joining the G-Rex Grant Program and joining our legion of likeminded collaborators Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. 👏
We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration
Wilson Wolf Manufacturing, LLC reposted this
We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration
We are thrilled to announce a groundbreaking collaboration with Multiply Labs , powered by G-Rex, the most automation-friendly bioreactor and most adopted static device, that can transform your manufacturing process! Together, we're aiming to democratize cell and gene therapy by developing user-friendly, high-throughput ballroom manufacturing solutions for the G-Rex platform. This collaboration will eliminate the need for highly skilled labor, making potentially lifesaving CGT drug products more accessible to patients worldwide. Read more about the partnership: https://lnkd.in/gTeX-ZqP #CellTherapy #GeneTherapy #CGTManufacturing #Partnership
We are so THRILLED to see that this breakthrough TIL therapy has #FDA approval. This brings hope to cancer patients worldwide and we celebrate alongside Iovance Biotherapeutics, Inc. Congratulations Iovance and the team on the monumentous occasion. #GRex #cancertreatment #cancerbreakthrough #celltherapy
Last week’s announcement has once again thrown the incredible promise of CGT therapies to the forefront of medicine! 🎉 Iovance Biotherapeutics, Inc. transformative advancement in cancer therapies crosses over to solid tumors. FDA approval of Iovance’s TIL (Tumor Infiltrating Lymphocyte) promises new hope for patients worldwide suffering from melanoma. 👏 This development represents a leap forward in our ongoing fight against cancer, offering more effective and personalized treatment options. Discover how this breakthrough can change the landscape of cancer treatment by watching the full video from NBC News. 📺 Watch now: https://lnkd.in/eHbswTFk #CancerCare #InnovativeTherapies #HealthcareInnovation #FightCancer #CGTCommunity #NBCNews #GRex #Celltherapymanufacturing
The power of G-Rex and ScaleReady Process Optimization expertise! ⬇ 🤩 SIMPLIFY your cell therapy manufacturing process with G-Rex. 🙀 Obtain unmatched cell expansion at a rate of 40 million/cm2 with G-Rex at every stage. and every size of G-Rex. 👩🔬 WITNESS unparalleled consistency and flexibility with G-Rex. Seamlessly scale from research to commercialization - reach out to one of our specialists today to learn how G-Rex can transform your process and move your discovery to market faster. >>>>>> info@scaleready.com 👈 #celltherapy #celltherapymanufacturing #genetherapy #clienttestimonial #CGT
PhD Candidate en GENyO. Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research
Scaling up 📈 Three years ago, culturing HSPCs was a nightmare for me. Fast forward to today, and it's almost surreal to witness the cultivation of such an amount of genetically modified HSPCs, with so little time-consuming maintenance. The progress is beyond what I could have imagined 👀 A huge shoutout to Paula Aguilar Solana for her invaluable assistance and unwavering support! 🤝 💜 #StemCulture #CultivationSucess #GRex #geneandcelltherapy
Common complex bioreactors mechanically perfuse media into cell culture devices due to an inherent limitation of conventional wisdom that necessitates low media height and consequently low volume to maintain cell viability. The G-Rex philosophy has exposed this paradigm as false, allowing cells to reside in a high media volume and eliminating the need to feed cells altogether. Contact your ScaleReady representative to learn how G-Rex bioreactors accomplish this: https://ow.ly/bwCQ50PXJaS #celltherapy #genetherapy #biotech
Watch Juan Vera, Chief Development Officer at Marker Therapeutics, Inc., discuss how Marker has used elements of ScaleReady's platform to simplify the manufacturing process of its multiple tumor-associated antigen (MultiTAA) T cell therapy in anticipation of commercialization. Watch: https://ow.ly/FmAX50PXJa6 #celltherapy #genetherapy #biotech
Did you know you can culture your cells for approximately 10 days without a media change when using G-Rex M Series bioreactors? Contact your ScaleReady representative to learn how to create a one-touch manufacturing process in G-Rex. https://ow.ly/pbOm50PXJ9C #celltherappy #genetherapy #biotech